menu
    • menu

    Company profile for Epirium

    NEW Drugs in Dev: 2
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical stage biopharmaceutical company that has uncovered unique insights into the biology of mitochondrial biogenesis and function, leading to an advanced understanding of its pleotropic clinical effect in disease. These findings have led to the discovery of a novel, previously undescribed pharmacological approach to the treatment of diseases characterized by deficits in these pathways. We have identified and estab...
    We are a clinical stage biopharmaceutical company that has uncovered unique insights into the biology of mitochondrial biogenesis and function, leading to an advanced understanding of its pleotropic clinical effect in disease. These findings have led to the discovery of a novel, previously undescribed pharmacological approach to the treatment of diseases characterized by deficits in these pathways. We have identified and established an IP-protected platform of small molecules that constitute a new class of therapeutics with the potential to stimulate mitochondrial biogenesis and function.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EpiriumUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4110 Campus Point Court San Diego, CA 92121
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://epirium.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Epirium Bio Gains FDA Nod for MF-300 Sarcopenia Trial
    Epirium Bio Gains FDA Nod for MF-300 Sarcopenia Trial

    27 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260127395210/en/Epirium-Bio-Announces-Positive-Type-C-End-of-Phase-1-Meeting-with-FDA-Supporting-Advancement-of-MF-300-to-a-Phase-2b-Clinical-Trial-in-Sarcopenia

    BUSINESSWIRE
    27 Jan 2026
    Share Share
    Epirium Bio Announces Phase 1 MF-300 Results in Older Adults
    Epirium Bio Announces Phase 1 MF-300 Results in Older Adults

    08 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260108769777/en/Epirium-Bio-Announces-Follow-on-Phase-1-Results-in-Older-Adult-Participants-for-MF-300-a-First-In-Class-Oral-15-PGDH-Enzyme-Inhibitor-for-the-Treatment-of-Sarcopenia

    BUSINESSWIRE
    08 Jan 2026
    Share Share
    Epirium Bio Presents Phase 1 MF-300 Muscle Data at AGS Conference
    Epirium Bio Presents Phase 1 MF-300 Muscle Data at AGS Conference

    17 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251117333357/en/Epirium-Bio-Presented-Positive-Phase-1-Safety-Pharmacokinetics-and-Pharmacodynamics-Data-for-MF-300-Supporting-its-Role-in-Muscle-Health-as-a-Late-Breaker-at-the-Gerontological-Society-of-America-Annual-Scientific-Meeting-2025

    BUSINESSWIRE
    17 Nov 2025
    Share Share
    Epirium Bio Reports Successful Ph 1 Trial Of MF-300 in Volunteers
    Epirium Bio Reports Successful Ph 1 Trial Of MF-300 in Volunteers

    24 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250924461947/en/Epirium-Bio-Announces-Positive-Phase-1-Clinical-Trial-Results-Evaluating-MF-300-in-Healthy-Volunteers-A-First-In-Class-Oral-15-PGDH-Enzyme-Inhibitor-For-the-Treatment-of-Sarcopenia

    BUSINESSWIRE
    24 Sep 2025
    Share Share
    Epirium Completes Dosing 1st-In-Human Ph1 MF-300 Sarcopenia Trial
    Epirium Completes Dosing 1st-In-Human Ph1 MF-300 Sarcopenia Trial

    21 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250721709030/en/Epirium-Bio-Completes-Dosing-in-First-In-Human-Phase-1-Clinical-Trial-Evaluating-MF-300-A-First-In-Class-Oral-15-PGDH-Enzyme-Inhibitor-For-the-Treatment-of-Sarcopenia

    BUSINESSWIRE
    21 Jul 2025
    Share Share
    Epirium Doses First Participants In MF-300 Sarcopenia Trial
    Epirium Doses First Participants In MF-300 Sarcopenia Trial

    30 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250130038128/en

    BUSINESSWIRE
    30 Jan 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search